Drugplain

Plegridy 125 ug/.5mL

peginterferon beta-1a · INJECTION, SOLUTION · Biogen Inc.

No Recall History
Plain English

Plegridy is an interferon beta medication given as an intramuscular injection used to treat relapsing forms of multiple sclerosis. It works by modulating the immune system to help reduce the frequency of relapses and slow disease progression.

Key Facts

Brand Name
Plegridy
Generic Name
peginterferon beta-1a
NDC Code (Product)
64406-017
Manufacturer
Biogen Inc.
Strength
125 ug/.5mL
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Marketing Status
Application #
BLA125499
Drug Class
Interferon beta [EPC]
Marketing Start
01/29/2021

Recall History

No Recall History

Frequently Asked Questions

What is Plegridy used for?

Plegridy is an interferon beta medication given as an intramuscular injection used to treat relapsing forms of multiple sclerosis. It works by modulating the immune system to help reduce the frequency of relapses and slow disease progression.

Is Plegridy a controlled substance?

Plegridy is not classified as a controlled substance by the DEA.

What is the generic name for Plegridy?

The generic name for Plegridy is peginterferon beta-1a. There are 2 other brand versions of peginterferon beta-1a.

What is the NDC code for Plegridy 125 ug/.5mL?

The NDC (National Drug Code) for Plegridy 125 ug/.5mL is 64406-017, listed by Biogen Inc..

Product NDC

64406-017

Package NDC

64406-017-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)